News Sentiment

TEVA sentiment intelligence

Teva Pharmaceutical Industries Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 52 Balanced news tone 14 relevant articles
Exchange TLV Israel
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 9432.00 Week of 19 Jun 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

82/100 classification confidence.

Company focus 14

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend inactive

-7.3% over one week, -6.1% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

How Teva’s Ecopipam Tourette NDA and AUSTEDO Data Will Impact Teva Pharmaceutical Industries (TEVA) Investors

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 82/100 classification
One-week reaction -7.3% Price reacting lower
Trend fit Trend inactive -6.1% over four weeks
Fair value 48.2% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 8
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 14
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 4
simplywall.st 2
Reuters 2
Stocktwits 1
GuruFocus 1
Moomoo 1
Seeking Alpha 1
The Jerusalem Post 1

Event Lens

What the news is about

Classified themes
Market update 10
Earnings 3
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-14 of 14